Fusion Pharmaceuticals Inc. Forms 3, 4 and 5: Warrants
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 1 rows, 1 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2020-06-30: Reporting owner JOHNSON & JOHNSON | Johnson & Johnson Innovation - JJDC, Inc.; Form 4; Security Warrants to purchase Common Shares; Transaction C Conversion of derivative security.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2020-06-30 | JOHNSON & JOHNSON | Johnson & Johnson Innovation - JJDC, Inc. 10% Owner | 10% Owner | 4 | Warrants to purchase Common Shares Derivative · Indirect · By Johnson & Johnson Innovation - JJDC, Inc. | C Conversion of derivative security | +89,118 89,118 owned after | $0.00 | 2020-07-02 |